Home Care Recommendations for Children with Influenza
For most children with influenza at home, focus on supportive care with close monitoring for warning signs, while antiviral treatment with oseltamivir should be strongly considered for all children under 5 years old and those with risk factors, ideally started within 48 hours of symptom onset. 1
Risk Stratification and Treatment Decisions
Children Who MUST Receive Antiviral Treatment
The AAP strongly recommends immediate oseltamivir treatment regardless of symptom duration for 1:
- Any child under 5 years of age with suspected or confirmed influenza
- Children with underlying high-risk conditions (chronic lung disease, heart disease, immunosuppression, neurologic disorders, diabetes, etc.)
- Any child with severe, complicated, or progressive illness
- Children whose household contacts are at high risk for complications
Children Where Treatment Should Be Considered
For otherwise healthy children ≥5 years with mild-to-moderate symptoms 1:
- Treatment is optional if started within 48 hours of symptom onset
- Benefits include shortened illness duration and reduced transmission to vulnerable household members
Oseltamivir Dosing for Home Treatment
Treatment duration: 5 days 1
Weight-based dosing (twice daily):
40 kg: 75 mg twice daily
- 23-40 kg: 60 mg twice daily
- 15-23 kg: 45 mg twice daily
- ≤15 kg: 30 mg twice daily
- Infants 9-11 months: 3.5 mg/kg per dose twice daily
- Term infants 3-8 months: 3 mg/kg per dose twice daily
- Term infants 0-3 months: 3 mg/kg per dose twice daily
Common side effects: Nausea, vomiting, headache (in infants: vomiting, skin reactions, diarrhea) 1
Essential Home Care Measures
Infection Control in the Household
Hand hygiene is the single most effective non-pharmaceutical intervention 2:
- Wash hands more than 5 times per day (shown to reduce infection risk by 38% in school-age children)
- Wash hands after touching potentially contaminated surfaces
- This is particularly critical for school-age children (5-17 years) where hand washing after touching contaminated surfaces reduced infection risk by 81% 2
Supportive Care Measures
While the guidelines focus primarily on antiviral therapy, basic supportive care includes:
- Adequate hydration
- Fever management (acetaminophen or ibuprofen as appropriate)
- Rest
- Monitoring for complications
Critical Warning Signs Requiring Medical Evaluation
Parents must monitor for signs of severe illness requiring immediate medical attention:
- Difficulty breathing or rapid breathing
- Bluish skin color
- Severe or persistent vomiting
- Signs of dehydration
- Altered mental status, confusion, or difficulty waking
- Seizures
- Severe muscle pain or weakness
- Worsening of chronic medical conditions
Common Pitfalls to Avoid
- Don't delay treatment waiting for test results in high-risk children when influenza is circulating in the community 1
- Don't withhold treatment beyond 48 hours in high-risk groups—while earlier is better, treatment can still be initiated at any time in hospitalized or severely ill children 1
- Don't use antibiotics unless there is clear evidence of bacterial superinfection (strong recommendation against routine use) 3
- Don't rely solely on fever resolution as a marker of recovery—monitor for secondary complications
Special Considerations
Infants under 3 months: Treatment is recommended despite limited safety data, as benefits outweigh risks. Chemoprophylaxis is generally not recommended in this age group unless the situation is critical 1
Breastfeeding: Should continue during maternal influenza with appropriate droplet precautions and hand hygiene 4
The evidence strongly supports that oseltamivir is the preferred antiviral agent for pediatric influenza based on cumulative experience, efficacy, safety, cost, and ease of administration 1. The 2026-2027 AAP guidelines represent the most current and authoritative recommendations for pediatric influenza management.